Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrapleural alteplase versus streptokinase in children with empyema
PACTR202306656398595Phase 3Not yet recruiting
- Sponsor
- Assiut University Children Hospital
- Start
- Mar 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of tissue-plasminogen activator and streptokinase in Empyema Thoracis and parapneumonic effusion (3 arms), sponsored by Assiut University Children Hospital. Primary endpoint: Benefit and complications of intrapleural fibrinolytics. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
tissue-plasminogen activatorstreptokinase
03
Conditions
Empyema Thoracisparapneumonic effusion
Beyond the preview
Go deeper on PACTR202306656398595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202306656398595.